Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Counting the cost

Article Abstract:

The economic implications of the Severe Acute Respiratory Syndrome (SARS) are discussed. The economic growth forecasts, employment, salaries, tourism collections, and hotel occupancies have been on the decline, since the outbreak. If the epidemic is severe, China will have to face serious economic consequences.

Author: Holland, Tom
Publisher: Review Publishing Company Ltd. (Hong Kong)
Publication Name: Far Eastern Economic Review
Subject: Business, international
ISSN: 0014-7591
Year: 2003
Epidemics, Severe acute respiratory syndrome

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Labour pains

Article Abstract:

There is a shortage of low-paid, unskilled labor force in China. The reasons for this dearth are poor working conditions coupled with low wages. In the event the industries opt to increase the wages, the country will face inflationary conditions

Author: Holland, Tom
Publisher: Review Publishing Company Ltd. (Hong Kong)
Publication Name: Far Eastern Economic Review
Subject: Business, international
ISSN: 0014-7591
Year: 2004
Personnel administration, Compensation and benefits, Work environment, Unskilled labor, Working conditions, Unskilled labour

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: China, Economic aspects
Similar abstracts:
  • Abstracts: Spending the blues away. Warning signs
  • Abstracts: Choosing the right combo. The score in 2004. Asian women targeted by Jasmine
  • Abstracts: Landing the big fish. Looking for a new President. Boom...and bust?
  • Abstracts: Spending to grow. Line of vision
  • Abstracts: From no name to brand name. Dynamic duets
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.